report-pricing-dollar

Medical Polymers Market

Pages:
205
View Count:
19571
Delivery Formats:
PDF PPT Excel
Medical Polymers Market

Lowest Price Guaranteed

download button Download Free Sample

sales@rootsanalysis.com

buynow button Buy Now

+44 (748) 188 1310

Medical Polymers Market by Type of Polymer (Thermoplastic Polymers, Elastomers, Thermoset Polymers and Other Polymers), Area of Application (Medical Devices, Excipients, Packaging, Other Applications) and Geographical Regions – Trends and Forecast 2026-2035

Market Size

The medical polymers market valued at USD 22.1 billion in 2025, is project to reach USD 23.5 billion in 2026 and USD 46.0 billion by 2035, representing a higher CAGR of 7.7% during the forecast period 2026 to 2035.

Global Medical Devices Market Growth 2026 to 2035

See What’s in the Full Report–Request Your Complimentary Insights!

Market Report: Key Takeaways

Market Size & Trends

  • In terms of type of polymer, the thermoplastic polymers segment holds the highest share of the market.
  • With regards to area of application, the medical devices segment dominates the global market.
  • Based on geographical regions, North America captures the majority of the market share (close to 50%).

Key Market Statistics

  • Market Size in 2026: $23.5 Billion
  • Estimated Market Size in 2035: $46.0 Billion
  • CAGR (2026-2035): 7.7%
  • North America: Largest market in 2026
  • Asia Pacific: Fastest growing region

Market Overview

Polymers represent a versatile class of materials composed of multiple simple chemical units, commonly known as monomers. Polymers are classified as natural and synthetic polymers based on their source of origin. It is worth highlighting that polymers are economical, highly durable, resistant to chemicals and light-weight in nature. As a result, polymers are used across various industries, including automotive, agriculture, construction, electronics, medical and textiles.

Medical grade polymers play a crucial role in the development and manufacturing of drug formulations (to enhance the solubilization of poorly soluble drugs, improve stability or encapsulate the drugs to mask their unpleasant taste), sustained release drug delivery systems (to control the release of drug over time or target specific tissues) and medical device (such as artificial joints, biosensors, dental implants, microfluidic devices, orthopedic implants and stents).

Driven by the significant advancements in this industry and rising demand for novel therapies and medical devices, the global medical polymers sector is likely to witness substantial market growth during the forecast period.

Pharmaceutical polymers / medical polymers have also played a significant role in the tissue engineering domain, as they are useful in the creation of scaffolds that can be employed to repair damaged tissues and wound care. Further, medical grade polymers are being used in 3D bioprinting to develop hydrogels / bioinks for soft tissue generation and other supporting structures.

Recent Developments in the Medical Polymers Market

  • In July 2025, Evonik entered into a distribution agreement with IMCD as the exclusive European distributor for RESOMER bioresorbable polymers used in implantable medical devices. The agreement expanded access across EEA countries, the UK, Switzerland, Turkey, Albania, Andorra, Monaco, Montenegro, San Marino, and Serbia, enhancing Evonik's medical polymer portfolio.
  • In February 2025, ALBIS entered into a collaboration with Arkema in order to distribute high-performance medical-grade polymers to strengthen their portfolio.
  • In February 2025, SABIC collaborated with US based medical device manufacturers to expand supply of high-performance resins for implants and diagnostic equipment, strengthening supply chain reliability and boosting SABIC’s presence in North America medical polymers market.
  • Rising Partnerships: Majority of the deals signed in this domain are instances of product development, representing nearly 30% of the total partnerships. Further, most of the intercontinental, as well as intracontinental deals have been inked by players based in Europe. In January 2024, Seqens entered into an agreement with Pleryon to develop and manufacture GMP polymers in order to treat osteoarthritis, at its facility in Aramon, France.
  • Portfolio Expansion: Companies are focusing on the expansion of its polymer portfolio across various geographies. One such expansion has been witnessed in October 2025 by LyondellBassel which entered into North America post becoming a trusted partner in Europe. Now, the Purell polyolefin portfolio will be available across North America.
  • Advancements in the Development of Biodegradable Polymers: Over the years, technological advancements in the medical polymers market have led to the development of novel, functional biodegradable polymers which are revolutionizing various applications, such as development of sutures, implants, and drug delivery systems by eliminating the need for surgical removal and further reducing long-term complications.
  • Focus on Sustainability: Another key trend observed in the pharmaceutical polymers / medical polymers industry is recycling polymer-based products / using innovative sustainable polymers in order to lower the production costs, optimize the usage of resources, reduce the waste generated and create a sustainable environment. In October 2025, LOG Pharma, along with Dow, showcased former’s innovative barrier eco line at CPHI Frankfurt. Based on Dow’s  pharma-grade Health+ polymer, the bottles created by LOG are 30% lighter, maintain superior gas and moisture barrier performance.

Industry Experts

Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes detailed transcripts of interviews conducted with the following individuals:

  • Chief Executive Officer and Chief Scientist, Small Company in the US
  • Business Development Manager, Small Company in Germany
  • Head of Marketing and Business Strategy, Large Company in Japan

Have Questions? Let’s Get Them Answered.

Medical Polymers Market Share Insights

Thermoplastic Polymers in Medical Polymers Industry Holds the Largest Share

  • The global medical polymers market is further divided into various sub-segments based on the type of polymer, such as thermoplastic polymers, elastomers, thermoset polymers and other polymers.
  • In 2026, the thermoplastic polymers segment (~65%) dominates the market, and is likely to grow at a relatively faster rate during the forecast period.
  • This is due to their ease of processing, biocompatibility, cost-effectiveness, and adaptability to recent advancements in healthcare systems.
Medical Polymers Market by Polymer Type 2026

Asia-Pacific to Propel in the Medical Polymers Sector in the Coming Years

  • According to our medical polymers market forecast, North America is likely to capture the majority (~50%) of the medical polymers sector share in 2025, and this trend is unlikely to change in the future.
  • It is worth highlighting that the market in Asia-Pacific is likely to grow at a relatively higher CAGR (~9.5%), during the forecast period. This is a result of the rising need for economical, biodegradable and eco-friendly medical grade polymers in this region.

Want Information on Specific Region/Segment?

Medical Devices Dominate the Medical Polymers Industry

  • In terms of area of application, the market is segmented into medical devices, excipients, packaging and other applications.
  • In 2026, the medical devices segment will hold the majority (∼50%) of the market share and is likely to grow at a relatively faster rate during the forecast period.
  • This is due to the growing demand for biodegradable polymers in healthcare market and a significant upsurge in the adoption of medical implants and other medical devices.
Medical Polymers Market by Application Area 2026
The detailed methodology across the global medical polymers market and revenue generated across various segments is available in the full report.

Key Market Insights

Competitive Landscape of Medical Polymer Companies

The current market landscape features more than 145 service providers including large, mid-sized and small companies. These companies have the required expertise to produce polymers for the biopharma / medical industry, across different geographical regions.

Notably, 60% of the medical polymer companies manufacture synthetic polymers. Further, medical grade polymers are poised to play a significant role in shaping up the future market landscape, by enabling the development of new therapeutic modalities and medical devices that were previously considered unattainable.

Pharmaceutical Polymers / Medical Polymers Market DELT Analysis

Opportunity for Medical Polymer Companies

The global medical polymers market size is likely to be worth $ 22.1 billion in 2025 and will reach $ 46.0 billion by 2035. In terms of the type of polymer, the thermoplastic polymers segment holds the largest share of the medical polymers domain. Also, the market size for these polymers is likely to grow at a higher CAGR of 7.5% during the forecast period. 

The continuous advancements of polymers in medical devices, development of novel, functional biodegradable polymers and smart polymers (also known as stimuli-responsive polymers or intelligent materials) and growing demand for novel medical grade polymers is likely to drive the medical polymers industry growth during the forecast period.

Regional Analysis

North America is Leading the Market

North American companies will dominate the global medical polymers domain in 2035. The majority (close to 75%) of medical polymer companies are headquartered in North America and Europe. This is due to the strong healthcare and medical device sectors and the ongoing innovation in medical polymers domain across these regions.

Asia-Pacific: An Emerging Growth Spot

The market in Asia-Pacific is likely to grow at a relatively high CAGR (9.5%), during the forecast period till 2035, as per medical polymers market report. This is due to several factors, including the rising need for economical, biodegradable and eco-friendly medical grade polymers.

Pharmaceutical Polymers / Medical Polymers Market Forecast, till 2035

What are the Key Drivers of Medical Polymers Market? Are Biodegradable Polymers Driving the Demand?

It is worth highlighting that there is a growing demand for biopolymers in healthcare markets owing to a significant upsurge in the demand for medical implants and other medical devices.

The rising production of novel pharmaceutical drugs has fueled the demand for polymers in formulation and stabilization. Further, various technological advances in this field and the rising demand for targeted drug delivery devices in the near future is likely to provide the necessary impetus to the market. Further, polymers have also been modified to exhibit antibacterial properties, thereby promoting their use in catheters and wound dressings to prevent infections. 

Pay Only for What You Need–The Best Way to Optimize

Market Segmentation Insights

Key Report Attributes Details
Historical Trend Since 2023
Forecast Period Till 2035
Market Size 2026 $ 23.5 Billion
Market Size 2035 $ 46.0 Billion
CAGR (Till 2035) 7.7%
Type of Polymer
  • Thermoplastic Polymers
  • Elastomers
  • Thermoset Polymers
  • Other Polymers
Area of Application
  • Medical Devices
  • Excipients
  • Packaging
  • Other Applications
Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and North Africa
Analytical Insights Covered
  • Market Landscape Analysis
  • Company Competitiveness Analysis
  • Partnerships and Collaborations
  • STEL Analysis
  • Market Forecast and Opportunity Analysis
Strategic Insights Covered
  • Executive Infographic Summary
  • A Case Study on Recent and Emerging Trends in Medical Polymers
Key Players
  • Key Players
  • Americhem
  • Borealis
  • Celanese
  • Corel Pharma Chem
  • Eastman
  • Henkel
  • KRAIBURG TPE
  • Kuraray
  • Lubrizol Life Science
  • LyondellBasell
  • Phon Tech
  • SEQENS
  • Sumitomo Chemical
  • Solvay
  • Zylog ElastoComp

(Full list of 145+ companies captured is available in the report)

PowerPoint Presentation (Complimentary) Available
Customization Scope 15% Free Customization

Frequently Asked Questions